News

Myelodysplastic Syndrome Market Epidemiology Report 2025-2035: Pipeline Therapies, Drugs Sales, And Regional Outlook
Myelodysplastic Syndrome Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 The report provides a detailed analysis of the current myelodysplastic ...
News Medical on MSN3d
New model to find treatments for an aggressive blood cancer
Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new ...
Targeted Oncology6d
Treatment Goals in Newly Diagnosed Lower-Risk MDS: Key Clinical and Genetic Factors
A panelist discusses the evolving role of luspatercept in low-risk myelodysplastic syndrome, highlighting its broad efficacy ...
Anadolu Agency2d
INTERVIEW – Echoes from Nagasaki: Survivors warn against devastation of nuclear war
As global threats grow, aging survivors of US atomic attacks on Japan feel growing urgency to remind the world of nuclear war ...
TuHURA Biosciences Completes Acquisition of Kineta
TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 immuno-oncology company developing novel technologies to ...
A new blood test may detect leukemia risk and replace bone marrow sampling
What if a blood test could reveal the pace of our aging – and the diseases that may lie ahead? The labs of Profs. Liran ...
Targeted Oncology6d
Case: A 70-Year-Old Man With Anemia in ESA-Naive Lower-Risk MDS
A panelist discusses a typical lower-risk myelodysplastic syndrome case managed with luspatercept over ...
Mac Churchill's Happy Soxx Offers A Clear-Eyed Look At Living With A Rare Medical Condition
Happy Soxx The memoir follows the author's experience with Myelodysplastic Syndrome and the life he continued to build beyond the diagnosis ...
Incurable blood cancer tied to gene mutation in new lab model
Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments ...